Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (81-90 of 220) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Improved response in high-risk neuroblastoma with protracted topotecan administration using a pharmacokinetically guided dosing approachVictor M Santana, Wayne L Furman, Catherine A Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumorsSheri L Spunt, Burgess B Freeman, Catherine A Billups, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Development and validation of limited sampling models for topotecan lactone pharmacokinetic studies in childrenP Kellie Turner, Lisa C Iacono, John C Panetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Exposure-Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for DosingOlivia Campagne, Bo Zhong, Sreenath Nair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumorsVictor M Santana, William C Zamboni, Mark N Kirstein, et al.
Investigative Ophthalmology & Visual Science|March 28, 2006
Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleationMatthew W Wilson, Charles H Fraga, Christine E Fuller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group studyRochelle Bagatell, Wendy B London, Lars M Wagner, et al.
Biochemical Pharmacology|April 5, 2011
MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transportFan Zhang, Stacy L Throm, Laura L Murley, et al.
Journal of Pediatric Surgery|January 9, 2007
Interferon beta-mediated vessel stabilization improves delivery and efficacy of systemically administered topotecan in a murine neuroblastoma modelPaxton V Dickson, Nikolaus L Hagedorn, John B Hamner, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|August 23, 2021
Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted TherapySara D A Angione, Alemayehu Y Akalu, Jessica Gartrell, et al.
Pageof 22

Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Improved response in high-risk neuroblastoma with protracted topotecan administration using a pharmacokinetically guided dosing approachVictor M Santana, Wayne L Furman, Catherine A Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumorsSheri L Spunt, Burgess B Freeman, Catherine A Billups, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Development and validation of limited sampling models for topotecan lactone pharmacokinetic studies in childrenP Kellie Turner, Lisa C Iacono, John C Panetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Exposure-Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for DosingOlivia Campagne, Bo Zhong, Sreenath Nair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumorsVictor M Santana, William C Zamboni, Mark N Kirstein, et al.
Investigative Ophthalmology & Visual Science|March 28, 2006
Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleationMatthew W Wilson, Charles H Fraga, Christine E Fuller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group studyRochelle Bagatell, Wendy B London, Lars M Wagner, et al.
Biochemical Pharmacology|April 5, 2011
MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transportFan Zhang, Stacy L Throm, Laura L Murley, et al.
Journal of Pediatric Surgery|January 9, 2007
Interferon beta-mediated vessel stabilization improves delivery and efficacy of systemically administered topotecan in a murine neuroblastoma modelPaxton V Dickson, Nikolaus L Hagedorn, John B Hamner, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|August 23, 2021
Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted TherapySara D A Angione, Alemayehu Y Akalu, Jessica Gartrell, et al.
Pageof 22